• 1
    Bickel M, Marben W, Betz C et al. End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years. HIV Med 2012; 14: 127135.
  • 2
    Mocroft A, Kirk O, Reiss P et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010; 24: 16671678.
  • 3
    Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 2009; 10: 329336.
  • 4
    Mocroft A, Ledergerber B, Katlama C et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 2229.
  • 5
    Vrouenraets SM, Fux CA, Wit FW et al. A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clin Nephrol 2012; 77: 311320.
  • 6
    Kowalska JD, Friis-Moller N, Kirk O et al. The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology 2011; 22: 516523.
  • 7
    d'Arminio A, Sabin CA, Phillips AN et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 2004; 18: 18111817.
  • 8
    Bansi L, Hughes A, Bhagani S et al. Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS 2009; 23: 25172521.
  • 9
    Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis 2011; 59: 620635.
  • 10
    Lucas GM, Mehta SH, Atta MG et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21: 24352443.
  • 11
    Bash LD, Astor BC, Coresh J. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010; 55: 3141.
  • 12
    Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. JASN 2006; 17: 22752284.
  • 13
    Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 15481557.
  • 14
    Foley RN, Collins AJ. The USRDS: what you need to know about what it can and can't tell us about ESRD. CJASN 2012 [Epub ahead of print].
  • 15
    Tourret J, Tostivint I, du Montcel ST et al. Outcome and prognosis factors in HIV-infected hemodialysis patients. CJASN 2006; 1: 12411247.
  • 16
    Mocroft A, Neuhaus J, Peters L et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS ONE 2012; 7: e40245.
  • 17
    Peters L, Grint D, Lundgren JD et al. HCV viremia increases the incidence of chronic kidney disease in HIV-infected patients. AIDS 2012; 26: 19171926.
  • 18
    O'Hare AM, Choi AI, Bertenthal D et al. Age affects outcomes in chronic kidney disease. JASN 2007; 18: 27582765.
  • 19
    Smith C, Sabin CA, Lundgren JD et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010; 24: 15371548.
  • 20
    Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin Infect Dis 2007; 45: 16251632.